Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Product revenue $ 606 $ 594
Costs of revenue 449 475
Gross profit 157 119
Operating expenses:    
Research and development 5,886 4,808
General and administrative 3,603 3,132
Sales and marketing 1,288 683
Total operating expenses 10,777 8,623
Loss from operations (10,620) (8,504)
Other income (expenses):    
Interest expense (2)
Interest income 101 330
Offering costs (1,246)
Forgiveness of PPP Loan 905
Change in fair value of derivative liabilities 696 2,111
Other income 143 282
Total other income, net 1,845 1,475
Net loss before income taxes (8,775) (7,029)
Provision for income taxes
Net loss (8,775) (7,029)
Deemed dividend related to beneficial conversion feature and accretion of discount on convertible preferred stock (9,565)
Net loss attributable to common stockholders $ (8,775) $ (16,594)
Net loss per share – basic and diluted    
Basic – net loss $ (0.36) $ (0.43)
Basic – deemed dividend and accretion of a discount on conversion of preferred stock (0.58)
Basic – attributable to common stockholders (0.36) (1.01)
Diluted – net loss (0.38) (0.53)
Diluted - deemed dividend and accretion of a discount on conversion of preferred stock (0.55)
Diluted – attributable to common stockholders $ (0.38) $ (1.08)
Weighted average common shares outstanding:    
Basic 24,691,902 16,406,556
Diluted 25,070,091 17,446,148